COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features

Levodopa is the most effective treatment in Parkinson’s disease and the association with COMT inhibitors widens its plasma bioavailability and effectiveness. Tolcapone is a potent COMT inhibitor whose utilization in PD is limited due to safety concerns on liver toxicity. However, recent data indicat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Antonini, Angelo, Abbruzzese, Giovanni, Barone, Paolo, Bonuccelli, Ubaldo, Lopiano, Leonardo, Onofrj, Marco, Zappia, Mario, Quattrone, Aldo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Dove Medical Press 2008
Θέματα:
Expert Opinion
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515921/
https://ncbi.nlm.nih.gov/pubmed/18728767
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια